Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-danthrusate (Dantron/docusate sodium)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-danthrusate 50mg/60mg/5ml oral suspension sugar free
0106020J0AAADAD
|
Co-danthrusate | Co-danthrusate (Dantron/docusate sodium) | Gastro-Intestinal System | 56 |
|
Co-danthrusate 50mg/60mg capsules
0106020J0AAAAAA
|
Co-danthrusate | Co-danthrusate (Dantron/docusate sodium) | Gastro-Intestinal System | 2 |
|
Capsuvac capsules
0106020J0BCAAAA
|
Capsuvac | Co-danthrusate (Dantron/docusate sodium) | Gastro-Intestinal System | No data available |
|
Normax capsules
0106020J0BBAAAA
|
Normax | Co-danthrusate (Dantron/docusate sodium) | Gastro-Intestinal System | No data available |
|
Normax oral suspension
0106020J0BBABAD
|
Normax | Co-danthrusate (Dantron/docusate sodium) | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.